BioSpace News Archive

The Janssen Pharmaceutical Companies of Johnson & Johnson announced the U.S. Food and Drug Administration has approved CABENUVA for the treatment of HIV-1 in virologically suppressed adolescents who are 12 years of age or older, weigh at least 35 kg and are on a stable antiretroviral regimen, with no history of treatment failure, nor known or suspected resistance to either cabotegravir or rilpivirine.

Elicio Therapeutics, a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer and other diseases, today announced positive preclinical data demonstrating that ELI-005, a protein subunit vaccine containing the spike receptor-binding domain (RBD) protein of SARS-CoV-2, and Elicio’s lymph node-targeted CpG TLR-9 agonist, Amphiphile-CpG (AMP-CpG), induce potent cross-reactive antibody and T cell responses in mice and non-human primates.

Milestone Scientific Inc. today announced that it will host a conference call at 8:30 AM Eastern Time on Friday, April 1, 2022 to discuss the company’s financial results for the 2021 fiscal year ended December 31, 2021, as well as the company’s corporate progress and other developments.

Keen Eye and Ultivue announce a collaborative agreement to promote multiplexed immunofluorescence (mIF) assays and scalable AI applications to unlock spatial analysis in clinical research.

Meridian Bioscience, Inc. announced today the launch of two new master mixes that detect DNA and RNA in crude blood samples down to a single copy – enabling the earliest detection of cancer using non-invasive liquid biopsy.

The digital map leverages Wake Forest’s validated diagnostic tool, the Self-administered Psoriasis Area Severity Index (SAPASI).

Partner Therapeutics, Inc., a commercial biotech company, announces publication of results from investigator-sponsored pre-clinical research evaluating use of recombinant murine GM-CSF to improve cognitive ability and brain pathology in an aged mouse model of Down syndrome and in aged normal mice.

According to Report, the global dental services market garnered revenue around US$ 298 Billion in 2020 and to reach over US$ 530 Billion by 2027 and expanding growth at a CAGR of 6% from 2021 to 2027.

According to Report, the global generic drugs market size is expected to rake US$ 565.13 billion by 2027 and expanding growth at a CAGR of 8.02% from 2021 to 2027.

OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, reported today its fourth quarter 2021 and full-year 2021 financial and operating results and provided a business update.